News about Quality / GMP

Dr. Reddy's Laboratories Limited's API facility at Srikakulam completes USFDA inspection successfully

Dr. Reddy's Laboratories Limited's API facility at Srikakulam completes USFDA inspection successfully

Quality / GMP | 20/07/2023 | By Sudeep Soparkar |  2695

US FDA Inspection at Aurobindo Pharma Ltd's Unit XIV, Anakapalli District, Andhra Pradesh

US FDA Inspection at Aurobindo Pharma Ltd's Unit XIV, Anakapalli District, Andhra Pradesh

Quality / GMP | 18/07/2023 | By Sudeep Soparkar |  709

Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP

Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP

Quality / GMP | 18/07/2023 | By Sudeep Soparkar |  662

Gland Pharma Limited - Conclusion of US FDA Inspection at Dundigal Facility, Hyderabad

Gland Pharma Limited - Conclusion of US FDA Inspection at Dundigal Facility, Hyderabad

Quality / GMP | 17/07/2023 | By Sudeep Soparkar |  1261

Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility

Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility

Quality / GMP | 13/07/2023 | By Sudeep Soparkar |  1091

USFDA inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations

USFDA inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations

Quality / GMP | 10/07/2023 | By Sudeep Soparkar |  1505

Zydus receives EIR from the USFDA for its SEZ 1 manufacturing facility at Pharmez, Ahmedabad

Zydus receives EIR from the USFDA for its SEZ 1 manufacturing facility at Pharmez, Ahmedabad

Quality / GMP | 06/07/2023 | By Sudeep Soparkar |  1374

Granules India Successfully Completes Two US FDA Audits in a Span of Two Weeks for its Vizag and Jeedimetla facilities with Zero Observations

Zero Observations indicate commitment to comply with best global standards

Quality / GMP | 06/07/2023 | By Sudeep Soparkar |  839

US FDA Inspection at Pashmylaram Facility, Hyderabad of Gland Pharma Ltd

US FDA Inspection at Pashmylaram Facility, Hyderabad of Gland Pharma Ltd

Quality / GMP | 28/06/2023 | By Sudeep Soparkar |  978

Ipca Laboratories Ltd receives 8 observations from USFDA for formulations facility at SEZ Indore, Pithampur

Ipca Laboratories Ltd receives 8 observations from USFDA for formulations facility at SEZ Indore, Pithampur

Quality / GMP | 26/06/2023 | By Sudeep Soparkar |  2418